HCA Healthcare, Inc. (NYSE:HCA) Shares Acquired by Steward Partners Investment Advisory LLC

Steward Partners Investment Advisory LLC increased its holdings in shares of HCA Healthcare, Inc. (NYSE:HCAFree Report) by 49.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 1,993 shares of the company’s stock after purchasing an additional 655 shares during the period. Steward Partners Investment Advisory LLC’s holdings in HCA Healthcare were worth $539,000 as of its most recent SEC filing.

A number of other large investors also recently bought and sold shares of HCA. CAP Partners LLC acquired a new stake in shares of HCA Healthcare during the 4th quarter worth about $281,000. Intech Investment Management LLC raised its stake in shares of HCA Healthcare by 13.7% during the fourth quarter. Intech Investment Management LLC now owns 78,802 shares of the company’s stock valued at $21,330,000 after purchasing an additional 9,492 shares during the period. Nomura Asset Management Co. Ltd. increased its stake in shares of HCA Healthcare by 17.7% in the fourth quarter. Nomura Asset Management Co. Ltd. now owns 62,533 shares of the company’s stock worth $16,926,000 after buying an additional 9,411 shares during the last quarter. Skopos Labs Inc. acquired a new position in HCA Healthcare in the fourth quarter worth $290,000. Finally, Team Hewins LLC acquired a new position in HCA Healthcare in the fourth quarter worth $313,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

HCA Healthcare Trading Down 0.1 %

NYSE:HCA opened at $336.67 on Friday. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $340.00. The company has a debt-to-equity ratio of 29.26, a current ratio of 1.16 and a quick ratio of 1.02. The stock has a market capitalization of $88.18 billion, a PE ratio of 16.78, a price-to-earnings-growth ratio of 1.54 and a beta of 1.69. The business’s 50-day simple moving average is $319.23 and its 200-day simple moving average is $309.99.

HCA Healthcare (NYSE:HCAGet Free Report) last released its quarterly earnings data on Friday, April 26th. The company reported $5.36 earnings per share for the quarter, beating the consensus estimate of $5.01 by $0.35. The business had revenue of $17.34 billion for the quarter, compared to analysts’ expectations of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. HCA Healthcare’s revenue for the quarter was up 11.2% on a year-over-year basis. During the same quarter in the previous year, the business posted $4.93 EPS. Sell-side analysts expect that HCA Healthcare, Inc. will post 20.86 earnings per share for the current fiscal year.

HCA Healthcare Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Friday, June 28th. Investors of record on Friday, June 14th will be issued a dividend of $0.66 per share. This represents a $2.64 dividend on an annualized basis and a dividend yield of 0.78%. The ex-dividend date of this dividend is Friday, June 14th. HCA Healthcare’s payout ratio is presently 13.16%.

Insider Buying and Selling

In other news, SVP Chad J. Wasserman sold 876 shares of the company’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the sale, the senior vice president now directly owns 1,576 shares in the company, valued at approximately $520,474. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. In other news, SVP Chad J. Wasserman sold 876 shares of the company’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $330.25, for a total transaction of $289,299.00. Following the completion of the sale, the senior vice president now directly owns 1,576 shares in the company, valued at approximately $520,474. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, EVP Michael S. Cuffe sold 6,311 shares of the company’s stock in a transaction on Thursday, May 9th. The stock was sold at an average price of $316.88, for a total value of $1,999,829.68. Following the sale, the executive vice president now owns 29,624 shares of the company’s stock, valued at $9,387,253.12. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,617 shares of company stock valued at $4,321,986. 1.60% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on HCA. Baird R W upgraded shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, May 30th. Barclays upped their target price on HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a research note on Monday, April 29th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $335.00 price target on shares of HCA Healthcare in a research report on Wednesday, April 10th. TD Cowen lowered their price target on HCA Healthcare from $371.00 to $360.00 and set a “buy” rating on the stock in a research report on Tuesday, April 30th. Finally, Deutsche Bank Aktiengesellschaft increased their target price on HCA Healthcare from $330.00 to $359.00 and gave the stock a “buy” rating in a report on Friday, April 12th. Four equities research analysts have rated the stock with a hold rating, fourteen have issued a buy rating and one has given a strong buy rating to the company’s stock. According to MarketBeat, HCA Healthcare has an average rating of “Moderate Buy” and an average price target of $325.59.

Check Out Our Latest Stock Report on HCA

HCA Healthcare Company Profile

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCAFree Report).

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.